Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$80.39 -2.71 (-3.26%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mirum Pharmaceuticals (MIRM) Amortization of Deferred Charges (2023 - 2026)

Updated

Analysis

Mirum Pharmaceuticals (MIRM) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Mirum Pharmaceuticals 5.14 Bn 3.55 Bn 145.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 658,000.00
Mar 31, 2026 454,000.00
Dec 31, 2025 436,000.00
Sep 30, 2025 443,000.00
Jun 30, 2025 427,000.00
Mar 31, 2025 433,000.00
Dec 31, 2024 416,000.00
Sep 30, 2024 424,000.00
Jun 30, 2024 407,000.00
Mar 31, 2024 414,000.00
Dec 31, 2023 399,000.00
Sep 30, 2023 411,000.00
Jun 30, 2023 307,000.00
API Access

Mirum Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=MIRM&period=max&api_key=YOUR_API_KEY